Published in Pharmaceuticals (PMID: 38675421), this 41-page open-access review proposes that BPC-157, while not meeting classical neurotransmitter criteria, functions as a cytoprotection mediator with neurotransmitter-like activity through a network of interconnected evidence. What Makes BPC-157 Unique BPC-157 is a 15-amino acid peptide (sequence: GEPPPGKPADDAGLV, molecular weight 1419) native and stable in human gastric juice for over 24 hours, showing no sequence homology with known gut peptides
Senotherapy, in contrast to conventional anti-cancer therapies (chemotherapy and radiotherapy), aims to inhibit the senescence process [9]
AMP research exploits their: Broad-spectrum bactericidal activity via membrane perturbation (colloido-osmotic mechanism, pore formation) Low resistance to bacterial selection (physical mechanism, little subject to mutation) Potential as antibiotic substitute in multi-resistance context Immunomodulatory activity : LL-37 stimulates leukocyte migration, neovascularisation, reepithelialisation In preclinical research, new-generation synthetic antimicrobial peptides (derivatives of magainin, indolicidin, protegrins) are tested on infected wound models
GHK-Cu works through copper-dependent enzymatic activation, TGF-beta signaling, antioxidant mechanisms, and broad gene expression modulation
There is no clinical evidence that NAD+ supplementation enhances tirzepatide's effects on weight loss or glycemic control